193 related articles for article (PubMed ID: 24068485)
1. Leukoencephalopathy due to oral methotrexate.
González-Suárez I; Aguilar-Amat MJ; Trigueros M; Borobia AM; Cruz A; Arpa J
Cerebellum; 2014 Feb; 13(1):178-83. PubMed ID: 24068485
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.
Ranganathan P; Culverhouse R; Marsh S; Mody A; Scott-Horton TJ; Brasington R; Joseph A; Reddy V; Eisen S; McLeod HL
J Rheumatol; 2008 Apr; 35(4):572-9. PubMed ID: 18381794
[TBL] [Abstract][Full Text] [Related]
3. Leukoencephalopathy induced by low-dose methotrexate in a patient with rheumatoid arthritis.
Matsuda M; Kishida D; Kinoshita T; Hineno A; Shimojima Y; Fukushima K; Ikeda S
Intern Med; 2011; 50(19):2219-22. PubMed ID: 21963744
[TBL] [Abstract][Full Text] [Related]
4. No correlation between MTHFR c.677 C > T, MTHFR c.1298 A > C, and ABCB1 c.3435 C > T polymorphisms and methotrexate therapeutic outcome of rheumatoid arthritis in West Algerian population.
Boughrara W; Benzaoui A; Aberkane M; Moghtit FZ; Dorgham S; Lardjam-Hetraf AS; Ouhaibi-Djellouli H; Teixeira EP; Boudjema A
Inflamm Res; 2017 Jun; 66(6):505-513. PubMed ID: 28299396
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.
Qiu Q; Huang J; Lin Y; Shu X; Fan H; Tu Z; Zhou Y; Xiao C
Medicine (Baltimore); 2017 Mar; 96(11):e6337. PubMed ID: 28296761
[TBL] [Abstract][Full Text] [Related]
6. Reversible leukoencephalopathy after oral methotrexate.
Koppen H; Wessels JA; Ewals JA; Treurniet FE
J Rheumatol; 2012 Sep; 39(9):1906-7. PubMed ID: 22942312
[No Abstract] [Full Text] [Related]
7. Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis.
Kato T; Hamada A; Mori S; Saito H
Drug Metab Pharmacokinet; 2012; 27(2):192-9. PubMed ID: 22104130
[TBL] [Abstract][Full Text] [Related]
8. Multifocal leukoencephalopathy in a patient medicated with etanercept and methotrexate for rheumatoid arthritis.
Yu T; Yang C
Z Rheumatol; 2024 May; 83(4):297-302. PubMed ID: 37755473
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta-analysis.
Fan H; Li Y; Zhang L; Li Y; Li W
Int J Rheum Dis; 2017 May; 20(5):526-540. PubMed ID: 28544525
[TBL] [Abstract][Full Text] [Related]
10. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
[TBL] [Abstract][Full Text] [Related]
12. Influence of MTHFR C677T polymorphism on methotrexate monotherapy discontinuation in rheumatoid arthritis patients: results from the GAPAID European project.
Uribarri M; Ruiz-Larrañaga O; Arteta D; Hernández L; Alcaro MC; Martínez A; Escorza-Treviño S; Estonba A; Migliorini P; Czirják L; del Amo J
Clin Exp Rheumatol; 2015; 33(5):699-705. PubMed ID: 26314492
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
[TBL] [Abstract][Full Text] [Related]
14. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
[TBL] [Abstract][Full Text] [Related]
15. Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.
Raghavendra S; Nair MD; Chemmanam T; Krishnamoorthy T; Radhakrishnan VV; Kuruvilla A
Eur J Neurol; 2007 Mar; 14(3):309-14. PubMed ID: 17355553
[TBL] [Abstract][Full Text] [Related]
16. Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report.
Yokoo H; Nakazato Y; Harigaya Y; Sasaki N; Igeta Y; Itoh H
Acta Neuropathol; 2007 Oct; 114(4):425-30. PubMed ID: 17357801
[TBL] [Abstract][Full Text] [Related]
17. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism.
Bohanec Grabar P; Logar D; Lestan B; Dolzan V
Eur J Clin Pharmacol; 2008 Nov; 64(11):1057-68. PubMed ID: 18607581
[TBL] [Abstract][Full Text] [Related]
18. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation.
Aggarwal P; Naik S; Mishra KP; Aggarwal A; Misra R
Indian J Med Res; 2006 Nov; 124(5):521-6. PubMed ID: 17213520
[TBL] [Abstract][Full Text] [Related]
19. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis.
Davis LA; Cannon GW; Pointer LF; Haverhals LM; Wolff RK; Mikuls TR; Reimold AM; Kerr GS; Richards JS; Johnson DS; Valuck R; Prochazka A; Caplan L
J Rheumatol; 2013 Jun; 40(6):809-17. PubMed ID: 23547211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
